(Q40845712)

24 September 2017

title

Captopril-induced skin eruptions (English)

1 reference

24 September 2017

Captopril-Induced Skin Eruptions (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

30 August 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

30 August 2023

author name string

Hayes AH Jr

6

1 reference

24 September 2017

J. R. Luderer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

D. P. Lookingbill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

D. W. Schneck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

L. M. Demers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

C. Cohen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

A. H. Hayes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6212598

30 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6212598

30 August 2023

publication date

1 April 1982

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1982.tb02156.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1982.tb02156.x/fullpdf

30 August 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

The Journal of Clinical Pharmacology

30 August 2023

published in

1 reference

24 September 2017

volume

22

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

151-159

1 reference

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Converting enzyme inhibition with an orally active compound in hypertensive man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

A specific orally active inhibitor of angiotensin-converting enzyme in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1982.TB02156.X

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

Prostaglandin synthesis by bovine mesenteric arteries and veins

30 August 2023

4

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

30 August 2023

7

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation

30 August 2023

11

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

Placental prostaglandin levels in pre-eclampsia

30 August 2023

12

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy

30 August 2023

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1982.TB02156.X

30 August 2023

Identifiers

1 reference

24 September 2017

1 reference